与血管相关的迁移细胞蛋白通过增强糖酸酶1酸化促进结直肠癌的进展
Wei Zhang1,2,3, Qian Shi4, Qincheng Liu5
1Fengcheng Hospital of Fengxian District Shanghai China.
Journal of cell communication and signaling
|June 18, 2025
概括
血管相关迁移细胞蛋白 (AAMP) 通过增强糖酸酶1 (PGK1) 酸化,驱动结直肠癌 (CRC) 的进展. 准AAMP-PGK1相互作用为高级CRC提供了潜在的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 结肠直肠癌 (CRC) 仍然是一个重大的全球健康挑战.
- 了解新的致癌驱动因素及其机制对于有效的治疗策略至关重要.
研究的目的:
- 研究血管相关迁移细胞蛋白 (AAMP) 在结直肠癌 (CRC) 中的作用.
- 阐明在CRC进展中链接AAMP和糖酸激酶1 (PGK1) 的分子机制.
主要方法:
- 在CRC组织中AAMP表达的分析,使用免疫组织化学和西欧血清.
- 在体外和体内功能性研究涉及siRNA淘汰和lentiviral过度表达的AAMP在CRC细胞系.
- 使用共免疫沉,酸化试验和RNA测序进行分子机制调查.
主要成果:
- 在CRC组织中,AAMP显著上调,与患者生存率差相关.
- 抑制AAMP会抑制CRC细胞增殖和瘤生长,而过度表达会增强这些表型.
- AAMP直接与PGK1酸化相互作用并增强,驱动CRC细胞增殖,并可能调节免疫通路.
结论:
- AAMP通过PGK1酸化依赖的代谢激活促进CRC进展.
- AAMP-PGK1轴代表了先进结直肠癌的一个有前途的治疗标.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Cancer Cell Migration through Invadopodia
2.4K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.4K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
IP3/DAG Signaling Pathway
12.5K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
12.5K
MAPK Signaling Cascades
6.2K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.2K


